Terms: = Brain cancer AND ATR, Q13535, 545, ENSG00000175054, MEC1, SCKL, SCKL1, FRP1 AND Prognosis
24 results:
1. Distinguishing IDH mutation status in gliomas using FTIR-atr spectra of peripheral blood plasma indicating clear traces of protein amyloid aggregation.
Kino S; Kanamori M; Shimoda Y; Niizuma K; Endo H; Matsuura Y
BMC Cancer; 2024 Feb; 24(1):222. PubMed ID: 38365669
[TBL] [Abstract] [Full Text] [Related]
2. Pan-mediastinal neoplasm diagnosis via nationwide federated learning: a multicentre cohort study.
Tang R; Liang H; Guo Y; Li Z; Liu Z; Lin X; Yan Z; Liu J; Xu X; Shao W; Li S; Liang W; Wang W; Cui F; He H; Yang C; Jiang L; Wang H; Chen H; Guo C; Zhang H; Gao Z; He Y; Chen X; Zhao L; Yu H; Hu J; Zhao J; Li B; Yin C; Mao W; Lin W; Xie Y; Liu J; Li X; Wu D; Hou Q; Chen Y; Chen D; Xue Y; Liang Y; Tang W; Wang Q; Li E; Liu H; Wang G; Yu P; Chen C; Zheng B; Chen H; Zhang Z; Wang L; Wang A; Li Z; Fu J; Zhang G; Zhang J; Liu B; Zhao J; Deng B; Han Y; Leng X; Li Z; Zhang M; Liu C; Wang T; Luo Z; Yang C; Guo X; Ma K; Wang L; Jiang W; Han X; Wang Q; Qiao K; Xia Z; Zheng S; Xu C; Peng J; Wu S; Zhang Z; Huang H; Pang D; Liu Q; Li J; Ding X; Liu X; Zhong L; Lu Y; Xu F; Dai Q; He J
Lancet Digit Health; 2023 Sep; 5(9):e560-e570. PubMed ID: 37625894
[TBL] [Abstract] [Full Text] [Related]
3. brain Metastasis Growth Kinetics: A Novel Prognosticator for Stereotactic Radiotherapy.
Lee SF; Yip PL; Chan OL; Lee VWY; Wong A; Choi HCW
Clin Oncol (R Coll Radiol); 2023 May; 35(5):e328-e335. PubMed ID: 36890037
[TBL] [Abstract] [Full Text] [Related]
4. Sarcoma brain metastases: Tertiary cancer center experience.
Ababneh HS; Muhsen B; Fares AS; Hirbawi H; Awabdeh TA; Hussaini MA; Amarin R; Mousa AA; Salah S
J Cancer Res Ther; 2023 Jan; 19(Suppl 2):S758-S763. PubMed ID: 38384052
[TBL] [Abstract] [Full Text] [Related]
5. RNF126-Mediated MRE11 Ubiquitination Activates the DNA Damage Response and Confers Resistance of Triple-Negative Breast cancer to Radiotherapy.
Liu W; Zheng M; Zhang R; Jiang Q; Du G; Wu Y; Yang C; Li F; Li W; Wang L; Wu J; Shi L; Li W; Zhang K; Zhou Z; Liu R; Gao Y; Huang X; Fan S; Zhi X; Jiang D; Chen C
Adv Sci (Weinh); 2023 Feb; 10(5):e2203884. PubMed ID: 36563124
[TBL] [Abstract] [Full Text] [Related]
6. ARPC1B promotes mesenchymal phenotype maintenance and radiotherapy resistance by blocking TRIM21-mediated degradation of IFI16 and HuR in glioma stem cells.
Gao Z; Xu J; Fan Y; Zhang Z; Wang H; Qian M; Zhang P; Deng L; Shen J; Xue H; Zhao R; Zhou T; Guo X; Li G
J Exp Clin Cancer Res; 2022 Nov; 41(1):323. PubMed ID: 36380368
[TBL] [Abstract] [Full Text] [Related]
7. Management of Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast cancer and brain Metastases: ASCO Guideline Update.
Ramakrishna N; Anders CK; Lin NU; Morikawa A; Temin S; Chandarlapaty S; Crews JR; Davidson NE; Franzoi MAB; Kirshner JJ; Krop IE; Patt DA; Perlmutter J; Giordano SH
J Clin Oncol; 2022 Aug; 40(23):2636-2655. PubMed ID: 35640075
[TBL] [Abstract] [Full Text] [Related]
8. Gene alternation of cerebrospinal fluid in patients with leptomeningeal metastases of lung adenocarcinoma using next-generation sequencing.
Yang H; Wen L; Pan Y; Shan C; Hong W; Wang H; Zhou C; Cai L; Zhou C
BMC Cancer; 2022 May; 22(1):580. PubMed ID: 35614407
[TBL] [Abstract] [Full Text] [Related]
9. Integrative analysis of therapy resistance and transcriptomic profiling data in glioblastoma cells identifies sensitization vulnerabilities for combined modality radiochemotherapy.
Schnöller LE; Albrecht V; Brix N; Nieto AE; Fleischmann DF; Niyazi M; Hess J; Belka C; Unger K; Lauber K; Orth M
Radiat Oncol; 2022 Apr; 17(1):79. PubMed ID: 35440003
[TBL] [Abstract] [Full Text] [Related]
10. Validated biomarker assays confirm that ARID1A loss is confounded with MMR deficiency, CD8
Heinze K; Nazeran TM; Lee S; Krämer P; Cairns ES; Chiu DS; Leung SC; Kang EY; Meagher NS; Kennedy CJ; Boros J; Kommoss F; Vollert HW; Heitz F; du Bois A; Harter P; Grube M; Kraemer B; Staebler A; Kommoss FK; Heublein S; Sinn HP; Singh N; Laslavic A; Elishaev E; Olawaiye A; Moysich K; Modugno F; Sharma R; Brand AH; Harnett PR; DeFazio A; Fortner RT; Lubinski J; Lener M; Tołoczko-Grabarek A; Cybulski C; Gronwald H; Gronwald J; Coulson P; El-Bahrawy MA; Jones ME; Schoemaker MJ; Swerdlow AJ; Gorringe KL; Campbell I; Cook L; Gayther SA; Carney ME; Shvetsov YB; Hernandez BY; Wilkens LR; Goodman MT; Mateoiu C; Linder A; Sundfeldt K; Kelemen LE; Gentry-Maharaj A; Widschwendter M; Menon U; Bolton KL; Alsop J; Shah M; Jimenez-Linan M; Pharoah PD; Brenton JD; Cushing-Haugen KL; Harris HR; Doherty JA; Gilks B; Ghatage P; Huntsman DG; Nelson GS; Tinker AV; Lee CH; Goode EL; Nelson BH; Ramus SJ; Kommoss S; Talhouk A; Köbel M; Anglesio MS
J Pathol; 2022 Apr; 256(4):388-401. PubMed ID: 34897700
[TBL] [Abstract] [Full Text] [Related]
11. brain Distribution of Berzosertib: An Ataxia Telangiectasia and Rad3-Related Protein Inhibitor for the Treatment of Glioblastoma.
Talele S; Zhang W; Burgenske DM; Kim M; Mohammad AS; Dragojevic S; Gupta SK; Bindra RS; Sarkaria JN; Elmquist WF
J Pharmacol Exp Ther; 2021 Dec; 379(3):343-357. PubMed ID: 34556535
[TBL] [Abstract] [Full Text] [Related]
12. Systemic Immune-Inflammation Index Predicts 3-Month Functional Outcome in Acute Ischemic Stroke Patients Treated with Intravenous Thrombolysis.
Weng Y; Zeng T; Huang H; Ren J; Wang J; Yang C; Pan W; Hu J; Sun F; Zhou X; Qiu H; Gao Y; Gao B; Chi L; Chen G
Clin Interv Aging; 2021; 16():877-886. PubMed ID: 34040364
[TBL] [Abstract] [Full Text] [Related]
13. Differences in Genomic Alterations Between brain Metastases and Primary Tumors.
Dono A; Takayasu T; Yan Y; Bundrant BE; Arevalo O; Lopez-Garcia CA; Esquenazi Y; Ballester LY
Neurosurgery; 2021 Feb; 88(3):592-602. PubMed ID: 33369669
[TBL] [Abstract] [Full Text] [Related]
14. Smoothened Promotes Glioblastoma Radiation Resistance Via Activating USP3-Mediated Claspin Deubiquitination.
Tu Y; Chen Z; Zhao P; Sun G; Bao Z; Chao H; Fan L; Li C; You Y; Qu Y; Chen Y; Ji J
Clin Cancer Res; 2020 Apr; 26(7):1749-1762. PubMed ID: 31900278
[TBL] [Abstract] [Full Text] [Related]
15. Anti-Tumour Activity of Glycodendrimer Nanoparticles in a Subcutaneous MEC-1 Xenograft Model of Human Chronic Lymphocytic Leukemia.
Ziemba B; Sikorska H; Jander M; Kuncman W; Danilewicz M; Appelhans D; Bryszewska M; Borowiec M; Franiak-Pietryga I
Anticancer Agents Med Chem; 2020; 20(3):325-334. PubMed ID: 31738155
[TBL] [Abstract] [Full Text] [Related]
16. Development of high-throughput atr-FTIR technology for rapid triage of brain cancer.
Butler HJ; Brennan PM; Cameron JM; Finlayson D; Hegarty MG; Jenkinson MD; Palmer DS; Smith BR; Baker MJ
Nat Commun; 2019 Oct; 10(1):4501. PubMed ID: 31594931
[TBL] [Abstract] [Full Text] [Related]
17. The SIAH1-HIPK2-p53ser46 Damage Response Pathway is Involved in Temozolomide-Induced Glioblastoma Cell Death.
He Y; Roos WP; Wu Q; Hofmann TG; Kaina B
Mol Cancer Res; 2019 May; 17(5):1129-1141. PubMed ID: 30796178
[TBL] [Abstract] [Full Text] [Related]
18. Induced Telomere Damage to Treat Telomerase Expressing Therapy-Resistant Pediatric brain Tumors.
Sengupta S; Sobo M; Lee K; Senthil Kumar S; White AR; Mender I; Fuller C; Chow LML; Fouladi M; Shay JW; Drissi R
Mol Cancer Ther; 2018 Jul; 17(7):1504-1514. PubMed ID: 29654065
[TBL] [Abstract] [Full Text] [Related]
19. Prognostic relevance of programmed cell death ligand 1 expression in glioblastoma.
Lee KS; Lee K; Yun S; Moon S; Park Y; Han JH; Kim CY; Lee HS; Choe G
J Neurooncol; 2018 Feb; 136(3):453-461. PubMed ID: 29147863
[TBL] [Abstract] [Full Text] [Related]
20. The Error-Prone DNA Polymerase κ Promotes Temozolomide Resistance in Glioblastoma through Rad17-Dependent Activation of atr-Chk1 Signaling.
Peng C; Chen Z; Wang S; Wang HW; Qiu W; Zhao L; Xu R; Luo H; Chen Y; Chen D; You Y; Liu N; Wang H
Cancer Res; 2016 Apr; 76(8):2340-53. PubMed ID: 26960975
[TBL] [Abstract] [Full Text] [Related]
[Next]
